FDA Announces The Establishment Of The OCE Equity Program (Catapult's regulatory round-up - May 2024)
Year: 2024
Type: other
Abstract: FDA Oncology Center of Excellence (OCE) announced the formation of The OCE Equity Program to improve access to clinical trials of oncology medical products for populations that have been historically underrepresented in clinical research, such as racial and ethnic minorities, individuals who live in rural areas, sexual and gender minorities, and individuals with economic, linguistic, or cultural barriers to healthcare services. The OCE Equity Program seeks to advance equitable access to clin...
Source: OpenEdition (OpenEdition)
DOI: 10.58079/12m7c
Author: Adelage
Language: English
Topic: Ethics in Clinical Research
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6973836917
Cites:
Cited by:
Related to: